Metraipolis › archive › dc_4cfca37d4e60

Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges — Europe PMC PMID:42506055

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42506055
DOI
10.3390/neurolint18070133
License (as archived)
solo-consultazione
Archived
2026-10-18T08:55:17.734Z
SHA-256 of the archived text
6fcbe3a9b92ae364aca365175e7a41b23cf06bde4adbc151e624c26b5a3501f9
Stable URL of this page
https://metraipolis.com/documento/dc_4cfca37d4e60

How to cite

Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges — Europe PMC PMID:42506055 — Europe PMC (en), https://europepmc.org/article/MED/42506055 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cfca37d4e60 (Metraipolis archive dc_4cfca37d4e60, sha256 6fcbe3a9b92ae364aca365175e7a41b23cf06bde4adbc151e624c26b5a3501f9)
BibTeX
@misc{dc4cfca37d4e60,
  title = {Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges — Europe PMC PMID:42506055},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42506055},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cfca37d4e60; sha256 6fcbe3a9b92ae364aca365175e7a41b23cf06bde4adbc151e624c26b5a3501f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42506055. Agents can read the archived copy with the MCP tool read_document.